During the past decade, Policlinico Universitario Campus Bio Medico conducted 81 clinical trials. In the 10-year time frame, 81 clinical trials started and 21 clinical trials were completed, i.e. on average, 25.9% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 17 clinical trials were completed. i.e. 51.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Policlinico Universitario Campus Bio Medico" #1 sponsor was "Italian Sarcoma Group" with 10 trials, followed by "Campus Bio-Medico University" with 6 trials sponsored, "Pfizer" with 5 trials sponsored, "Celgene" with 4 trials sponsored and "Fondazione del Piemonte per l'Oncologia" with 4 trials sponsored. Other sponsors include 63 different institutions and companies that sponsored additional 55 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Policlinico Universitario Campus Bio Medico" #1 collaborator was "PharmaMar" with 4 trials as a collaborator, "Clinical Research Technology S.r.l." with 2 trials as a collaborator, "Helsinn Healthcare SA" with 2 trials as a collaborator, "1Med" with 1 trials as a collaborator and "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Policlinico Universitario Campus Bio Medico" are "Ulcerative Colitis" (5 trials), "Breast Cancer" (3 trials), "Advanced Cholangiocarcinoma" (2 trials), "Dedifferentiated Liposarcoma" (2 trials) and "Follicular Lymphoma" (2 trials). Many other conditions were trialed in "Policlinico Universitario Campus Bio Medico" in a lesser frequency.

Most popular intervention types in "Policlinico Universitario Campus Bio Medico" are "Drug" (68 trials), "Procedure" (9 trials), "Other" (8 trials), "Device" (6 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Trabectedin" (6 trials), "Gemcitabine" (5 trials), "Cyclophosphamide" (3 trials) and "Rituximab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Policlinico Universitario Campus Bio Medico" are 90 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Policlinico Universitario Campus Bio Medico". undefined are not yet recruiting, 16 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Policlinico Universitario Campus Bio Medico, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Policlinico Universitario Campus Bio Medico, 3 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 11 trials that are defined as “Not Applicable".

Policlinico Universitario Campus Bio Medico has several departments that took part in Clinical trials: "Divisione Ematologia - Università Campus Bio-Medico" - 12 trials, "Policlinico Universitario Campus Biomedico; Uoc Oncologia Medica" - 12 trials, "Campus Biomedico - Cardiologia" - 4 trials, "Institute of Neurology, Campus Biomedico University" - 3 trials